Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2013, Article ID 895147, 11 pages
http://dx.doi.org/10.1155/2013/895147
Review Article

Smoking and Age-Related Macular Degeneration: Review and Update

1Department of Ophthalmology, San Pedro Hospital, Carretera de Piqueras 98, 26006 Logroño, Spain
2RETICS Oftared, Instituto de Salud Carlos III, 28029 Madrid, Spain
3Department of Ophthalmology, Reina Sofia General University Hospital, Avenida Intendente Jorge Palacios 1, 30003 Murcia, Spain
4Department of Ophthalmology and Optometry, Faculty of Medicine, University of Murcia, 301000 Murcia, Spain
5Ophthalmic Research Unit “Santiago Grisolía,” Department of Surgery/Ophthalmology, Faculty of Medicine and Odontology, University of Valencia, Avenida Blasco Ibanez 15, 46010 Valencia, Spain
6Department of Ophthalmology, University Clinic of Navarra, Avenida de Pio XII 36, 31008 Pamplona, Spain
7Department of Ophthalmology, University and Polytechnic Hospital La Fe, Carretera Bulevar Sur, 46026 Valencia, Spain
8Faculty of Medicine and Odontology, University of Valencia, Avenida Blasco Ibanez 15, 46010 Valencia, Spain
9Gómez-Ulla Institute of Ophthalmology, Calla Maruxa Mallo 3, 15706 Santiago de Compostela, Spain
10University of Santiago de Compostela, Carretera San Francisco, 15705 Santiago de Compostela, Spain
11Retina Division, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
12Vitreoretinal Division, King Khaled Eye Specialist Hospital, Riyhad 12329, Saudi Arabia

Received 15 July 2013; Revised 14 September 2013; Accepted 3 October 2013

Academic Editor: Gabriele Thumann

Copyright © 2013 Sara Velilla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Attebo, P. Mitchell, and W. Smith, “Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study,” Ophthalmology, vol. 103, no. 3, pp. 357–364, 1996. View at Google Scholar · View at Scopus
  2. M. G. Maguire, S. B. Bressler, N. M. Bresskr et al., “Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration,” Archives of Ophthalmology, vol. 115, no. 6, pp. 741–747, 1997. View at Google Scholar · View at Scopus
  3. C. C. W. Klaver, R. C. W. Wolfs, J. R. Vingerling, A. Hofman, and P. T. V. M. De Jong, “Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam study,” Archives of Ophthalmology, vol. 116, no. 5, pp. 653–658, 1998. View at Google Scholar · View at Scopus
  4. R. J. Casten, B. W. Rovner, and W. Tasman, “Age-related macular degeneration and depression: a review of recent research,” Current Opinion in Ophthalmology, vol. 15, no. 3, pp. 181–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. D. S. Friedman, B. J. O'Colmain, B. Muñoz et al., “Prevalence of age-related macular degeneration in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 564–572, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Lotery, X. Xu, G. Zlatava, and J. Loftus, “Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study,” British Journal of Ophthalmology, vol. 91, no. 10, pp. 1303–1307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. D. Jager, W. F. Mieler, and J. W. Miller, “Age-related macular degeneration,” New England Journal of Medicine, vol. 358, pp. 2606–2617, 2006. View at Google Scholar
  8. R. Gallego-Pinazo, R. Dolz-Marco, and M. Díaz-Llopis, “Towards the new spectral-domain optical coherence tomography based classification of age-related macular degeneration,” Archivos de la Sociedad Española de Oftalmología, vol. 87, no. 8, pp. 247–252, 2012. View at Google Scholar
  9. R. Klein, B. E. K. Klein, S. C. Jensen, and S. M. Meuer, “The five-year incidence and progression of age-related maculopathy: the beaver dam eye study,” Ophthalmology, vol. 104, no. 1, pp. 7–21, 1997. View at Google Scholar · View at Scopus
  10. J. M. Seddon, “Epidemiology of age-related macular degeneration,” in Retina, A. P. Schachat and S. Ryan, Eds., pp. 1039–1050, Mosby, St. Louis, Mo, USA, 3rd edition, 2001. View at Google Scholar
  11. U. Chakravarthy, T. Y. Wong, A. Fletcher et al., “Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis,” BMC Ophthalmology, vol. 10, no. 1, article 31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Klein, T. Peto, A. Bird, and M. R. Vannewkirk, “The epidemiology of age-related macular degeneration,” American Journal of Ophthalmology, vol. 137, no. 3, pp. 486–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Seddon and L. Sobrin, “Epidemiology of age-related macular degeneration,” in Albert and Jakobiec’s Principles and Practice of Ophthalmology, D. Albert, J. Miller, D. Azar, and B. Blodi, Eds., vol. 1, pp. 413–422, Saunders, Philadelphia, Pa, USA, 3rd edition, 2008. View at Google Scholar
  14. P. T. V. M. de Jong, “Age-related macular degeneration,” New England Journal of Medicine, vol. 355, no. 14, pp. 1474–1485, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Seddon, U. A. Ajani, R. D. Sperduto et al., “Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration,” Journal of the American Medical Association, vol. 272, no. 18, pp. 1413–1420, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Seddon, W. C. Willett, F. E. Speizer, and S. E. Hankinson, “A prospective study of cigarette smoking and age-related macular degeneration in women,” Journal of the American Medical Association, vol. 276, no. 14, pp. 1141–1146, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Seddon, J. Cote, N. Davis, and B. Rosner, “Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio,” Archives of Ophthalmology, vol. 121, no. 6, pp. 785–792, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Seddon, J. Cote, and B. Rosner, “Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake,” Archives of Ophthalmology, vol. 121, no. 12, pp. 1728–1737, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Seddon, B. Rosner, R. D. Sperduto et al., “Dietary fat and risk for advanced age-related macular degeneration,” Archives of Ophthalmology, vol. 119, no. 8, pp. 1191–1199, 2001. View at Google Scholar · View at Scopus
  20. R. Klein, B. E. K. Klein, and K. L. P. Linton, “Prevalence of age-related maculopathy. The Beaver Dam Eye Study,” Ophthalmology, vol. 99, no. 6, pp. 933–943, 1992. View at Google Scholar · View at Scopus
  21. J. R. Vingerling, I. Dielemans, A. Hofman et al., “The prevalence of age-related maculopathy in the Rotterdam study,” Ophthalmology, vol. 102, no. 2, pp. 205–210, 1995. View at Google Scholar · View at Scopus
  22. P. Mitchell, W. Smith, K. Attebo, and J. J. W. Jie Jin Wang, “Prevalence of age-related maculopathy in Australia: the blue mountains eye study,” Ophthalmology, vol. 102, no. 10, pp. 1450–1460, 1995. View at Google Scholar · View at Scopus
  23. S. C. Tomany, J. J. Wang, R. Van Leeuwen et al., “Risk factors for incident age-related macular degeneration: pooled findings from 3 continents,” Ophthalmology, vol. 111, no. 7, pp. 1280–1287, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Klein, B. E. K. Klein, K. L. P. Linton, and D. L. DeMets, “The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking,” American Journal of Epidemiology, vol. 137, no. 2, pp. 190–200, 1993. View at Google Scholar · View at Scopus
  25. R. Klein, K. J. Cruickshanks, S. D. Nash et al., “The prevalence of age-related macular degeneration and associated risk factors,” Archives of Ophthalmology, vol. 128, no. 6, pp. 750–758, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. R. Vingerling, A. Hofman, D. E. Grobbee, and P. T. V. M. De Jong, “Age-related macular degeneration and smoking: the Rotterdam study,” Archives of Ophthalmology, vol. 114, no. 10, pp. 1193–1196, 1996. View at Google Scholar · View at Scopus
  27. W. Smith, P. Mitchell, and S. R. Leeder, “Smoking and age-related maculopathy: the blue mountains eye study,” Archives of Ophthalmology, vol. 114, no. 12, pp. 1518–1523, 1996. View at Google Scholar · View at Scopus
  28. P. Mitchell, S. Chapman, and W. Smith, “Smoking is a major cause of blindness,” Medical Journal of Australia, vol. 171, no. 4, pp. 173–174, 1999. View at Google Scholar · View at Scopus
  29. C. A. McCarty, B. N. Mukesh, C. L. Fu, P. Mitchell, J. J. W. Jie Jin Wang, and H. R. Taylor, “Risk factors for age-related maculopathy: the visual impairment project,” Archives of Ophthalmology, vol. 119, no. 10, pp. 1455–1462, 2001. View at Google Scholar · View at Scopus
  30. W. Smith, J. Assink, R. Klein et al., “Risk factors for age-related macular degeneration: pooled findings from three continents,” Ophthalmology, vol. 108, no. 4, pp. 697–704, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. J. E. Ardourel, “Risk factors associated with age-related macular degeneration: a case-control study in the Age-Related Eye Disease Study: age-related eye disease Study report number 3,” Ophthalmology, vol. 107, no. 12, pp. 2224–2232, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. “Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group,” Archives of Ophthalmology, vol. 110, pp. 1701–1708, 1992.
  33. C. Delcourt, J.-L. Diaz, A. Ponton-Sanchez, and L. Papoz, “Smoking and age-related macular degeneration: the POLA study,” Archives of Ophthalmology, vol. 116, no. 8, pp. 1031–1035, 1998. View at Google Scholar · View at Scopus
  34. B. G. Moon, S. G. Joe, J. U. Hwang, H. K. Kim, J. Choe, and Y. H. Yoon, “Prevalence and risk factors of early-stage age-related macular degeneration in patients examined at a health promotion center in Korea,” Journal of Korean Medical Science, vol. 27, pp. 537–541, 2012. View at Google Scholar
  35. P. Cackett, I. Yeo, C. M. G. Cheung et al., “Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons,” Ophthalmology, vol. 118, no. 5, pp. 846–852, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Klein, B. E. K. Klein, and S. E. Moss, “Relation of smoking to the incidence of age-related maculopathy. The beaver dam eye study,” American Journal of Epidemiology, vol. 147, no. 2, pp. 103–110, 1998. View at Google Scholar · View at Scopus
  37. R. Klein, B. E. K. Klein, S. C. Tomany, and S. E. Moss, “Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study,” American Journal of Epidemiology, vol. 156, no. 7, pp. 589–598, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Mitchell, J. Jin Wang, W. Smith, and S. R. Leeder, “Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study,” Archives of Ophthalmology, vol. 120, no. 10, pp. 1357–1363, 2002. View at Google Scholar · View at Scopus
  39. J. S. L. Tan, P. Mitchell, A. Kifley, V. Flood, W. Smith, and J. W. Jie, “Smoking and the long-term incidence of age-related macular degeneration: the blue mountains eye study,” Archives of Ophthalmology, vol. 125, no. 8, pp. 1089–1095, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. W. G. Christen, R. J. Glynn, J. E. Manson, U. A. Ajani, and J. E. Buring, “A prospective study of cigarette smoking and risk of age-related macular degeneration in men,” Journal of the American Medical Association, vol. 276, no. 14, pp. 1147–1151, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. R. C. Milton, T. E. Clemons, R. Klien, J. M. Seddon, and F. L. Ferris III, “Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19,” Ophthalmology, vol. 112, no. 4, pp. 533–539, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. L. Coleman, R. L. Seitzman, S. R. Cummings et al., “The association of smoking and alcohol use with age-related macular degeneration in the oldest old. The Study of Osteoporotic Fractures,” American Journal of Ophthalmology, vol. 149, no. 1, pp. 160–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Cong, B. Zhou, Q. Sun, H. Gu, N. Tang, and B. Wang, “Smoking and the risk of age-related macular degeneration: a meta-analysis,” Annals of Epidemiology, vol. 18, no. 8, pp. 647–656, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Tamakoshi, M. Yuzawa, M. Matsui, M. Uyama, N. K. Fujiwara, and Y. Ohno, “Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case-control study in Japan,” British Journal of Ophthalmology, vol. 81, no. 10, pp. 901–904, 1997. View at Google Scholar · View at Scopus
  45. J. Fowles and E. Dybing, “Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke,” Tobacco Control, vol. 12, no. 4, pp. 424–430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. F. Roth, A. Bindewald, and F. G. Holz, “Keypathophysiologic pathways in age-related macular disease,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 242, no. 8, pp. 710–716, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. N. L. Benowitz, “Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment,” Progress in Cardiovascular Diseases, vol. 46, no. 1, pp. 91–111, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Heeschen, J. J. Jang, M. Weis et al., “Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis,” Nature Medicine, vol. 7, no. 7, pp. 833–839, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Heeschen, E. Chang, A. Aicher, and J. P. Cooke, “Endothelial progenitor cells participate in nicotine-mediated angiogenesis,” Journal of the American College of Cardiology, vol. 48, no. 12, pp. 2553–2560, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Yu, Q. Liu, J. Sun, K. Yi, L. Wu, and X. Tan, “Nicotine improves the functional activity of late endothelial progenitor cells via nicotinic acetylcholine receptors,” Biochemistry and Cell Biology, vol. 89, no. 4, pp. 405–410, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Kiuchi, M. Matsuoka, J. C. Wu et al., “Mecamylamine suppresses basal and nicotine-stimulated choroidal neovascularization,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1705–1711, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. B.-Q. Zhu and W. W. Parmley, “Hemodynamic and vascular effects of active and passive smoking,” American Heart Journal, vol. 130, no. 6, pp. 1270–1275, 1995. View at Publisher · View at Google Scholar · View at Scopus
  53. A. P. Brogan, T. J. Dickerson, G. E. Boldt, and K. D. Janda, “Altered retinoid homeostasis catalyzed by a nicotine metabolite: implications in macular degeneration and normal development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 30, pp. 10433–10438, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. E. C. Hoffman, H. Reyes, F.-F. Chu et al., “Cloning of a factor required for activity of the Ah (dioxin) receptor,” Science, vol. 252, no. 5008, pp. 954–958, 1991. View at Google Scholar · View at Scopus
  55. H. Reyes, S. Reisz-Porszasz, and O. Hankinson, “Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor,” Science, vol. 256, no. 5060, pp. 1193–1195, 1992. View at Google Scholar · View at Scopus
  56. A. Takeuchi, M. Takeuchi, K. Oikawa et al., “Effects of dioxin on vascular endothelial growth factor (VEGF) production in the retina associated with choroidal neovascularization,” Investigative Ophthalmology and Visual Science, vol. 50, no. 7, pp. 3410–3416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Beatty, H.-H. Koh, M. Phil, D. Henson, and M. Boulton, “The role of oxidative stress in the pathogenesis of age-related macular degeneration,” Survey of Ophthalmology, vol. 45, no. 2, pp. 115–134, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Cai, K. C. Nelson, M. Wu, J. Sternberg P., and D. P. Jones, “Oxidative damage and protection of the RPE,” Progress in Retinal and Eye Research, vol. 19, no. 2, pp. 205–221, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Lee and J. P. Cooke, “Nicotine and pathological angiogenesis,” Life Sciences, vol. 91, pp. 1058–1064, 2012. View at Google Scholar
  60. N. K. Wills, V. M. S. Ramanujam, J. Chang et al., “Cadmium accumulation in the human retina: effects of age, gender, and cellular toxicity,” Experimental Eye Research, vol. 86, no. 1, pp. 41–51, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. P. J. Deisinger, T. S. Hill, and J. C. English, “Human exposure to naturally occurring hydroquinone,” Journal of Toxicology and Environmental Health, vol. 47, no. 1, pp. 31–46, 1996. View at Google Scholar · View at Scopus
  62. A. P. DeCaprio, “The toxicology of hydroquinone—relevance to occupational and environmental exposure,” Critical Reviews in Toxicology, vol. 29, no. 3, pp. 283–330, 1999. View at Publisher · View at Google Scholar · View at Scopus
  63. G. M. Holtkamp, A. F. De Vos, R. Peek, and A. Kijlsta, “Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-β2) by human retinal pigment epithelial cells,” Clinical and Experimental Immunology, vol. 118, no. 1, pp. 35–40, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Uetama, K. Ohno-Matsui, K.-I. Nakahama, I. Morita, and M. Mochizuki, “Phenotypic change regulates monocyte chemoattractant protein-1 (MCP-1) gene expression in human retinal pigment epithelial cells,” Journal of Cellular Physiology, vol. 197, no. 1, pp. 77–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Pons and M. E. Marin-Castaño, “Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo,” PLoS ONE, vol. 6, no. 2, Article ID e16722, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. D. G. Espinosa-Heidmann, I. J. Suner, P. Catanuto, E. P. Hernandez, M. E. Marin-Castano, and S. W. Cousins, “Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD,” Investigative Ophthalmology and Visual Science, vol. 47, no. 2, pp. 729–737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. I. A. Bhutto, D. S. McLeod, T. Hasegawa et al., “Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration,” Experimental Eye Research, vol. 82, no. 1, pp. 99–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. C. A. Martey, S. J. Pollock, C. K. Turner et al., “Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 287, no. 5, pp. L981–L991, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. S. D. Shapiro, “Smoke gets in your cells,” American Journal of Respiratory Cell and Molecular Biology, vol. 31, no. 5, pp. 481–482, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. C. J. Baglole, P. J. Sime, and R. P. Phipps, “Cigarette smoke-induced expression of heme oxygenase-1 in human lung fibroblasts is regulated by intracellular glutathione,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 295, no. 4, pp. L624–L636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. K. M. Bertram, C. J. Baglole, R. P. Phipps, and R. T. Libby, “Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration,” American Journal of Physiology: Cell Physiology, vol. 297, no. 5, pp. C1200–C1210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. A. L. Yu, K. Birke, J. Burger, and U. Welge-Lussen, “Biological effects of cigarette smoke in cultured human retinal pigment epithelial cells,” PLoS ONE, vol. 7, Article ID 48501, 2012. View at Google Scholar
  73. A. L. Yu, R. Fuchshofer, D. Kook, A. Kampik, H. Bloemendal, and U. Welge-Lüssen, “Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-β release,” Investigative Ophthalmology and Visual Science, vol. 50, no. 2, pp. 926–935, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. K. Mishima, J. T. Handa, A. Aotaki-Keen, G. A. Lutty, L. S. Morse, and L. M. Hjelmeland, “Senescence-associated β-galactosidase histochemistry for the primate eye,” Investigative Ophthalmology and Visual Science, vol. 40, no. 7, pp. 1590–1593, 1999. View at Google Scholar · View at Scopus
  75. P. Dumont, M. Burton, Q. M. Chen et al., “Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast,” Free Radical Biology and Medicine, vol. 28, no. 3, pp. 361–373, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. O. Toussaint, E. E. Medrano, and T. Von Zglinicki, “Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes,” Experimental Gerontology, vol. 35, no. 8, pp. 927–945, 2000. View at Publisher · View at Google Scholar · View at Scopus
  77. M. L. Katz and W. G. Robison Jr., “What is lipofuscin? Defining characteristics and differentiation from other autofluorescent lysosomal storage bodies,” Archives of Gerontology and Geriatrics, vol. 34, no. 3, pp. 169–184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  78. J. R. Sparrow and M. Boulton, “RPE lipofuscin and its role in retinal pathobiology,” Experimental Eye Research, vol. 80, no. 5, pp. 595–606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. L. Jia, Z. Liu, L. Sun et al., “Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-α-lipoic acid,” Investigative Ophthalmology and Visual Science, vol. 48, no. 1, pp. 339–348, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. Z. Liu, L. Sun, L. Zhu et al., “Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction,” Journal of Neurochemistry, vol. 103, no. 6, pp. 2690–2700, 2007. View at Google Scholar · View at Scopus
  81. A. H. Conney, “Induction of microsomal enzymes for foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture,” Cancer Research, vol. 42, no. 12, pp. 4875–4917, 1982. View at Google Scholar · View at Scopus
  82. W. P. Patton, M. N. Routledge, G. D. Jones et al., “Retinal pigment epithelial cell DNA is damaged by exposure to benzo[a]pyrene, a constituent of cigarette smoke,” Experimental Eye Research, vol. 74, no. 4, pp. 513–522, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Sharma, A. Neekhra, A. L. Gramajo et al., “Effects of Benzo(e)Pyrene, a toxic component of cigarette smoke, on human retinal pigment epithelial cells in vitro,” Investigative Ophthalmology and Visual Science, vol. 49, no. 11, pp. 5111–5117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. K. C. Dunn, A. E. Aotaki-Keen, F. R. Putkey, and L. M. Hjelmeland, “ARPE-19, a human retinal pigment epithelial cell line with differentiated properties,” Experimental Eye Research, vol. 62, no. 2, pp. 155–169, 1996. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Sharma, J. A. Patil, A. L. Gramajo, G. M. Seigel, B. D. Kuppermann, and C. M. Kenney, “Effects of hydroquinone on retinal and vascular cells in vitro,” Indian Journal of Ophthalmology, vol. 60, pp. 189–193, 2012. View at Google Scholar
  86. L. Wang, M. E. Clark, D. K. Crossman et al., “Abundant lipid and protein components of drusen,” PLoS ONE, vol. 5, no. 4, Article ID e10329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Fujihara, N. Nagai, T. E. Sussan, S. Biswal, and J. T. Handa, “Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice,” PLoS ONE, vol. 3, no. 9, Article ID e3119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. C. W. Spraul, G. E. Lang, and H. E. Grossniklaus, “Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 37, no. 13, pp. 2724–2735, 1996. View at Google Scholar · View at Scopus
  89. R. J. Ross, V. Verma, K. I. Rosenberg, C. C. Chan, and J. Tuo, “Genetic markers and biomarkers for age-related macular degeneration,” Expert Review of Ophthalmology, vol. 2, pp. 443–457, 2007. View at Google Scholar
  90. T. W. Kim, J. W. Kang, J. Ahn et al., “Proteomic analysis of the aqueous humor in age-related macular degeneration (AMD) patients,” Journal of Proteome Research, vol. 11, no. 8, pp. 4034–4043.
  91. J. Yao, X. Liu, Q. Yang et al., “Proteomic analysis of the aqueous humor in patients with wet age-related macular degeneration,” Proteomics, 2013. View at Publisher · View at Google Scholar
  92. J. M. Seddon, G. Gensler, R. C. Milton, M. L. Klein, and N. Rifai, “Association between C-reactive protein and age-related macular degeneration,” Journal of the American Medical Association, vol. 291, no. 6, pp. 704–710, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. J. M. Seddon, S. George, B. Rosner, and N. Rifai, “Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers,” Archives of Ophthalmology, vol. 123, no. 6, pp. 774–782, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. J. Gibson, S. Hakobyan, A. J. Cree et al., “Variation in complement component C1 inhibitor in age-related macular degeneration,” Immunobiology, vol. 217, no. 2, pp. 251–255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. F. Ozguner, A. Koyu, and G. Cesur, “Active smoking causes oxidative stress and decreases blood melatonin levels,” Toxicology and Industrial Health, vol. 21, no. 1-2, pp. 21–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  96. L. Jia, Y. Dong, H. Yang, X. Pan, R. Fan, and L. Zhai, “Serum superoxide dismutase and malondialdehyde levels in a group of Chinese patients with age-related macular degeneration,” Aging, vol. 23, no. 4, pp. 264–267, 2011. View at Google Scholar · View at Scopus
  97. X. Shen, L. H. Jia, P. Zhao et al., “Changes in blood oxidative and antioxidant parameters in a group of Chinese patients with age-related macular degeneration,” Journal of Nutrition, Health and Aging, vol. 16, pp. 201–204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. D. G. Yanbaeva, M. A. Dentener, E. C. Creutzberg, G. Wesseling, and E. F. M. Wouters, “Systemic effects of smoking,” Chest, vol. 131, no. 5, pp. 1557–1566, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. O. P. Heinonen and D. Albanes, “The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers,” New England Journal of Medicine, vol. 330, no. 15, pp. 1029–1035, 1994. View at Publisher · View at Google Scholar · View at Scopus
  100. G. S. Omenn, G. E. Goodman, M. D. Thornquist et al., “Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease,” New England Journal of Medicine, vol. 334, no. 18, pp. 1150–1155, 1996. View at Publisher · View at Google Scholar · View at Scopus
  101. Age-Related Eye Disease Study Research Group, “A randomized, placebo-controlled, clinical trial of highdose supplementationwith vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8,” Archives of Ophthalmology, vol. 119, pp. 1417–1436, 2001. View at Google Scholar
  102. Age-Related Eye Disease Study 2 Research Group, “Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial,” Journal of the American Medical Association, vol. 309, pp. 2005–2015, 2013. View at Google Scholar
  103. S. Lee, S. J. Song, and H. G. Yu, “Current smoking is associated with a poor visual acuity improvement after intravitreal ranibizumab therapy in patients with exudative age-related macular degeneration,” Journal of Korean Medical Science, vol. 28, pp. 769–774, 2013. View at Google Scholar
  104. M. McKibbin, M. Ali, S. Bansal et al., “CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration,” British Journal of Ophthalmology, vol. 96, no. 2, pp. 208–212, 2012. View at Publisher · View at Google Scholar · View at Scopus
  105. A. E. Hughes, N. Orr, C. Patterson et al., “Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking,” PLoS Medicine, vol. 4, article e355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. C. A. Rennie, A. Stinge, E. A. King, S. Sothirachagan, C. Osmond, and A. J. Lotery, “Can genetic risk information for age-related macular degeneration influence motivation to stop smoking A pilot study,” Eye, vol. 26, no. 1, pp. 109–118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. R. R. Priya, E. Y. Chew, and A. Swaroop, “Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management,” Ophthalmology, vol. 119, pp. 2526–2536, 2012. View at Google Scholar
  108. E. M. Stone, A. J. Aldave, A. V. Drack et al., “Recommendations for genetic testing of inherited eye diseases. Report of the American Academy of Ophthalmology Task Force on Genetic Testing,” Ophthalmology, vol. 119, pp. 2408–2410, 2012. View at Google Scholar